Literature DB >> 28646675

Conformational regulation of CRISPR-associated nucleases.

Ryan N Jackson1, Paul Bg van Erp2, Samuel H Sternberg3, Blake Wiedenheft4.   

Abstract

Adaptive immune systems in bacteria and archaea rely on small CRISPR-derived RNAs (crRNAs) to guide specialized nucleases to foreign nucleic acids. The activation of these nucleases is controlled by a series of molecular checkpoints that ensure precise cleavage of nucleic acid targets, while minimizing toxic off-target cleavage events. In this review, we highlight recent advances in understanding regulatory mechanisms responsible for controlling the activation of these nucleases and identify emerging regulatory themes conserved across diverse CRISPR systems.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28646675      PMCID: PMC5687066          DOI: 10.1016/j.mib.2017.05.010

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.934


  77 in total

1.  Crystal Structure of Staphylococcus aureus Cas9.

Authors:  Hiroshi Nishimasu; Le Cong; Winston X Yan; F Ann Ran; Bernd Zetsche; Yinqing Li; Arisa Kurabayashi; Ryuichiro Ishitani; Feng Zhang; Osamu Nureki
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

2.  Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells.

Authors:  Xuebing Wu; David A Scott; Andrea J Kriz; Anthony C Chiu; Patrick D Hsu; Daniel B Dadon; Albert W Cheng; Alexandro E Trevino; Silvana Konermann; Sidi Chen; Rudolf Jaenisch; Feng Zhang; Phillip A Sharp
Journal:  Nat Biotechnol       Date:  2014-04-20       Impact factor: 54.908

3.  Crystal structure of the CRISPR-Cas RNA silencing Cmr complex bound to a target analog.

Authors:  Takuo Osawa; Hideko Inanaga; Chikara Sato; Tomoyuki Numata
Journal:  Mol Cell       Date:  2015-04-23       Impact factor: 17.970

4.  Cas1 and the Csy complex are opposing regulators of Cas2/3 nuclease activity.

Authors:  MaryClare F Rollins; Saikat Chowdhury; Joshua Carter; Sarah M Golden; Royce A Wilkinson; Joseph Bondy-Denomy; Gabriel C Lander; Blake Wiedenheft
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

Review 5.  Type III CRISPR-Cas Immunity: Major Differences Brushed Aside.

Authors:  Gintautas Tamulaitis; Česlovas Venclovas; Virginijus Siksnys
Journal:  Trends Microbiol       Date:  2016-10-20       Impact factor: 17.079

6.  Structure and Engineering of Francisella novicida Cas9.

Authors:  Hisato Hirano; Jonathan S Gootenberg; Takuro Horii; Omar O Abudayyeh; Mika Kimura; Patrick D Hsu; Takanori Nakane; Ryuichiro Ishitani; Izuho Hatada; Feng Zhang; Hiroshi Nishimasu; Osamu Nureki
Journal:  Cell       Date:  2016-02-11       Impact factor: 41.582

7.  Discovery and Functional Characterization of Diverse Class 2 CRISPR-Cas Systems.

Authors:  Sergey Shmakov; Omar O Abudayyeh; Kira S Makarova; Yuri I Wolf; Jonathan S Gootenberg; Ekaterina Semenova; Leonid Minakhin; Julia Joung; Silvana Konermann; Konstantin Severinov; Feng Zhang; Eugene V Koonin
Journal:  Mol Cell       Date:  2015-10-22       Impact factor: 17.970

8.  In vitro reconstitution of an Escherichia coli RNA-guided immune system reveals unidirectional, ATP-dependent degradation of DNA target.

Authors:  Sabin Mulepati; Scott Bailey
Journal:  J Biol Chem       Date:  2013-06-11       Impact factor: 5.157

9.  Two distinct DNA binding modes guide dual roles of a CRISPR-Cas protein complex.

Authors:  Timothy R Blosser; Luuk Loeff; Edze R Westra; Marnix Vlot; Tim Künne; Małgorzata Sobota; Cees Dekker; Stan J J Brouns; Chirlmin Joo
Journal:  Mol Cell       Date:  2015-03-05       Impact factor: 17.970

10.  GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases.

Authors:  Shengdar Q Tsai; Zongli Zheng; Nhu T Nguyen; Matthew Liebers; Ved V Topkar; Vishal Thapar; Nicolas Wyvekens; Cyd Khayter; A John Iafrate; Long P Le; Martin J Aryee; J Keith Joung
Journal:  Nat Biotechnol       Date:  2014-12-16       Impact factor: 54.908

View more
  26 in total

1.  Structural basis of Type IV CRISPR RNA biogenesis by a Cas6 endoribonuclease.

Authors:  Hannah N Taylor; Emily E Warner; Matthew J Armbrust; Valerie M Crowley; Keith J Olsen; Ryan N Jackson
Journal:  RNA Biol       Date:  2019-06-28       Impact factor: 4.652

2.  Second Messenger cA4 Formation within the Composite Csm1 Palm Pocket of Type III-A CRISPR-Cas Csm Complex and Its Release Path.

Authors:  Ning Jia; Roger Jones; George Sukenick; Dinshaw J Patel
Journal:  Mol Cell       Date:  2019-07-17       Impact factor: 17.970

3.  CRISPR-Cas III-A Csm6 CARF Domain Is a Ring Nuclease Triggering Stepwise cA4 Cleavage with ApA>p Formation Terminating RNase Activity.

Authors:  Ning Jia; Roger Jones; Guangli Yang; Ouathek Ouerfelli; Dinshaw J Patel
Journal:  Mol Cell       Date:  2019-07-17       Impact factor: 17.970

Review 4.  Class 2 CRISPR-Cas RNA-guided endonucleases: Swiss Army knives of genome editing.

Authors:  Stefano Stella; Pablo Alcón; Guillermo Montoya
Journal:  Nat Struct Mol Biol       Date:  2017-10-16       Impact factor: 15.369

Review 5.  Structures and Strategies of Anti-CRISPR-Mediated Immune Suppression.

Authors:  Tanner Wiegand; Shweta Karambelkar; Joseph Bondy-Denomy; Blake Wiedenheft
Journal:  Annu Rev Microbiol       Date:  2020-06-05       Impact factor: 15.500

6.  A Type IV-A CRISPR-Cas System in Pseudomonas aeruginosa Mediates RNA-Guided Plasmid Interference In Vivo.

Authors:  Valerie M Crowley; Adam Catching; Hannah N Taylor; Adair L Borges; Josie Metcalf; Joseph Bondy-Denomy; Ryan N Jackson
Journal:  CRISPR J       Date:  2019-11-27

7.  Conformational Dynamics of DNA Binding and Cas3 Recruitment by the CRISPR RNA-Guided Cascade Complex.

Authors:  Paul B G van Erp; Angela Patterson; Ravi Kant; Luke Berry; Sarah M Golden; Brittney L Forsman; Joshua Carter; Ryan N Jackson; Brian Bothner; Blake Wiedenheft
Journal:  ACS Chem Biol       Date:  2017-12-12       Impact factor: 5.100

8.  Structure Reveals a Mechanism of CRISPR-RNA-Guided Nuclease Recruitment and Anti-CRISPR Viral Mimicry.

Authors:  MaryClare F Rollins; Saikat Chowdhury; Joshua Carter; Sarah M Golden; Heini M Miettinen; Andrew Santiago-Frangos; Dominick Faith; C Martin Lawrence; Gabriel C Lander; Blake Wiedenheft
Journal:  Mol Cell       Date:  2019-03-11       Impact factor: 17.970

9.  A phage-encoded anti-CRISPR enables complete evasion of type VI-A CRISPR-Cas immunity.

Authors:  Alexander J Meeske; Ning Jia; Alice K Cassel; Albina Kozlova; Jingqiu Liao; Martin Wiedmann; Dinshaw J Patel; Luciano A Marraffini
Journal:  Science       Date:  2020-05-28       Impact factor: 47.728

10.  RNA Binding and HEPN-Nuclease Activation Are Decoupled in CRISPR-Cas13a.

Authors:  Akshay Tambe; Alexandra East-Seletsky; Gavin J Knott; Jennifer A Doudna; Mitchell R O'Connell
Journal:  Cell Rep       Date:  2018-07-24       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.